[Event Report] Roundtable – The Increasing Role of Japanese Pharmaceutical Companies in Global Health (December 11, 2018)
date : 1/7/2019
Tags: Global Health, Other activities
![[Event Report] Roundtable – The Increasing Role of Japanese Pharmaceutical Companies in Global Health (December 11, 2018)](https://hgpi.org/en/wp-content/uploads/sites/2/PC110232-1.jpg)
HGPI convened a roundtable on “The Increasing Role of Japanese Pharmaceutical Companies in Global Health.” This meeting was held in accordance with online publication of “Access to Medicine Index 2018” by the Access to Medicine Foundation (published on November 20, 2018).
The roundtable was jointly hosted by the Access to Medicine Foundation, the Health and Global Policy Institute (HGPI), and the Japan International Cooperation Agency (JICA). Support was also provided by the Japanese Ministry of Foreign Affairs (MOFA).
■Seminar Overview
Date and Time:Tuesday, December 11, 2018 08:30 to 10:30
Venue :Grand Cube 3F, Otemachi Financial City, Global Business Hub Tokyo
Program:
08:30-08:35 Opening Remarks
Yasuhiro Suzuki(Chief Medical and Global Health Officer and Vice-Minister for Health, Ministry of Health, Labour and Welfare of Japan)
08:35-09:00 Access to Medicine Index 2018: Key Findings
Danny Edwards(Research Program Manager, Access to Medicine Foundation)
09:00-09:30 Q&A
09:30-09:40 Discussants: Building on the results of the 2018 Access to Medicine Index
Sumi Manabu(Director, Global Health Policy Division, International Cooperation Bureau, Ministry of Foreign Affairs of Japan)
Ritsuko Yamagata(Director, Health Team 2, Human Development Department, Japan International Cooperation Agency)
09:40-10:25 Discussion
10:25-10:30 Closing Remarks
Damiano de Felice(Director of Strategy, Access to Medicine Foundation)
Top Research & Recommendations Posts
- [Policy Recommendation] Preparing for “Disaster-Level Heat” in the 2025 Basic Policy on Economic and Fiscal Management and Reform (June 9, 2025)
- [Research Report] The 2025 Public Opinion Survey on Healthcare in Japan (March 17, 2025)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Policy Recommendations] HGPI Joint Input to the Zero Draft Political Declaration on NCDs and Mental Health (May 23, 2025)
- [Policy Recommendation] Integrating “Planetary Health” as a Growth Strategy — Proposal for the Grand Design and Action Plan for a New Form of Capitalism (2025 Revised Edition) (June 9, 2025)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Policy Recommendations] Recommendation for the Basic Policy on Economic and Fiscal Management and Reform 2025 (May 29, 2025)
- [Public Comment Submission] “Voluntary National Review on Sustainable Development Goals” (April 18, 2025)
- [Research Report] Survey of Japanese Nursing Professionals Regarding Climate Change and Health (Final Version) (November 14, 2024)
Featured Posts
-
2025-06-09
[Policy Recommendation] Preparing for “Disaster-Level Heat” in the 2025 Basic Policy on Economic and Fiscal Management and Reform (June 9, 2025)
-
2025-06-09
[Policy Recommendation] Integrating “Planetary Health” as a Growth Strategy — Proposal for the Grand Design and Action Plan for a New Form of Capitalism (2025 Revised Edition) (June 9, 2025)
-
2025-06-16
[Registration Open] (Webinar) The 135th HGPI Seminar “A Warning from the Heat That Threatens Lives – Rethinking Heatstroke Prevention in the Era of Climate Change” (July 1, 2025)